| Project/Area Number |
03454392
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Chiba University |
|---|
Principal Investigator |
INABA Noriyuki Chiba University Faculty of Medicine Assistant Professor, 医学部, 講師 (70114238)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
FUKASAWA Ichiro Chiba University University Hospital Assistant Professor, 医学部, 講師 (00189911)
岩崎 秀昭 千葉大学, 医学部附属病院, 講師 (60124244)
|
|---|
| Project Period (FY) |
1991 – 1993
|
| Project Status |
Completed (Fiscal Year 1993)
|
| Budget Amount *help |
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 1993: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1992: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1991: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
|---|
| Keywords | HCV / Carrier / Pregnancy / Sexual transmission / Materno-infantile transmission / 垂直感染 / 夫妻間感染 |
|---|
| Research Abstract |
Under the collaboration of 32 obstetrical institutions in Chiba Prefecture, we investigated 1)diganostic means of HCV carrier-stage, 2)HCV carrier rate in pregnant women (incl : silent carrier), 3)HCV clustering in the familial memebers of carrier pregnant women, 4)potential HCV materno-infantile and/or sexual transmission, and got the results as follows :
1)Five of 59 infants (8.5%) born to HCV carrier mothers were found to develop carrier state. 2)Four of the 5 carrier infants revealed the same genotype to their own mothers, while one child developed two mixed genotypes (one was similar to its mother). 3)All of the 5 carrier infants acquired active immunity against HCV, which was confirmed by the reelevation of serum HCV-related Ab titers. 4)HCV-RNA was always detectable by PCR up to 47 weeks after birth in 4 of the 5 carrier infants (80%). In one infant, HCV-RNA was detectable until 8 months in age, but became negative at 12 months and remained negative up to 24 months. 5)Abnormal elevation of serum ALT levels was found in 80% of the carrier infants.
|
